{"corpus_id":226206577,"paper_sha":"2baf65ad0c5950ac6246e0837f8503788aea1b5f","doi":"10.1093/pubmed/fdaa196","arxiv_id":null,"pmid":33124667,"pmcid":"7665601","mag_id":3096660133,"dblp_id":null,"acl_id":null,"title":"The views of ethnic minority and vulnerable communities towards participation in COVID-19 vaccine trials","year":2020,"publication_date":"2020-10-30","venue":"Journal of public health","journal":{"name":"Journal of Public Health (Oxford, England)","pages":null,"volume":null},"journal_issn":null,"journal_title":null,"publication_types":["JournalArticle"],"pubmed_pub_types":["Journal Article","Research Support, Non-U.S. Gov't"],"s2_fields_of_study":["Sociology","Medicine"],"reference_count":7,"citation_count":47,"influential_citation_count":2,"is_open_access":true,"arxiv_categories":null,"arxiv_license":null,"arxiv_journal_ref":null,"mesh_headings":[{"d":"COVID-19","mj":true,"ui":"D000086382"},{"d":"COVID-19 Vaccines","mj":true,"ui":"D000086663"},{"d":"Ethnicity","mj":false,"ui":"D005006"},{"d":"Humans","mj":false,"ui":"D006801"},{"d":"Minority Groups","mj":false,"ui":"D008913"},{"d":"SARS-CoV-2","mj":false,"ui":"D000086402"}],"chemicals":[{"n":"COVID-19 Vaccines","ui":"D000086663","reg":"0"}],"comments_corrections":null,"source_flags":5,"s2_open_access_pdf_url":"https://academic.oup.com/jpubhealth/article-pdf/43/2/e258/38502703/fdaa196.pdf","s2_open_access_landing_url":"https://www.semanticscholar.org/paper/2baf65ad0c5950ac6246e0837f8503788aea1b5f","s2_open_access_license":"other-oa","s2_open_access_status":"HYBRID","pmc_open_access_pdf_url":null,"pmc_open_access_landing_url":null,"pmc_open_access_license":null,"pmc_open_access_status":null,"unpaywall_open_access_pdf_url":null,"unpaywall_open_access_landing_url":null,"unpaywall_open_access_license":null,"unpaywall_open_access_status":null,"abstract":"The COVID-19 pandemic has disproportionately affected Black, Asian and minority ethnic populations and vulnerable groups.1 Ethnic minority communities have 10–50% higher mortality risk compared with those of white ethnicity in the UK and USA.2,3 Those with mental health conditions, homeless people and vulnerable migrants are also at high risk.4,5 If successful, vaccination will provide protection and management of COVID-19, and to ensure optimal uptake and efficacy of vaccination programmes, the involvement of high-risk groups in vaccine trials is crucial. Ethnic minority individuals are, however, generally underrepresented in medical research, and researchers are actively seeking approaches to include more ethnic minorities in COVID-19 vaccine trials.6 There is, therefore, a pressing need to explore perceptions towards participation in vaccine trials amongst ethnic minority and vulnerable communities towards achieving higher recruitment rates. A qualitative investigation involving three focus groups and 47 semi-structured interviews were conducted through virtual platforms and telephone calls with n = 70 individuals from different ethnic and vulnerable groups, in July–August 2020. They were recruited through existing Patient and Public Involvement (PPI) networks and included South Asian (n = 30), African and Afro-Caribbean (n = 17), White Polish (n = 4), White British (n = 3) and 15 representatives of other vulnerable groups [mental health, homeless and Gypsy, Roma and Travellers (GRT) communities]. Participants were part of an existing PPI network; hence, ethical approval was waived. Verbal informed consent was obtained from all participants. Feelings towards hospital attendance for COVID-19 vaccine trials and research were explored. Responses were recorded, transcribed and analysed using a thematic approach. There was broad agreement that clinical research was necessary, but most interviewees were extremely uncomfortable with the idea of attending hospitals for vaccine trials and any research requiring physical examinations or blood tests. Primary concerns included fears of contracting COVID-19, side effects, lack of support if problems arose and language barriers. Participants were also suspicious of hidden agendas behind vaccines. They had strong views on the need for transparency at all stages of trials, from vaccine development to outcomes, and for supporting information that reflected cultural appropriateness. Some issues were more strongly expressed amongst certain groups (e.g. religious concerns amongst South Asians and the need for third sector involvement for homeless people and mental health sufferers). Key barriers and facilitators to participation in trials are outlined in Table 1. The lack of adequate information influenced widespread apprehension, scepticism and low levels of trust towards vaccine research. Developing interventions to increase participation in vaccine trials will require consideration of the heterogeneous nature of ethnic minority and vulnerable groups. Additional requirement will be the reassurance of hospital safety, or use of neutral settings for trials is essential to alleviate fears of getting infected with COVID-19. Addressing the concerns highlighted by each group will need targeted information, resources and support services if we are serious about having representative populations for vaccine and other therapeutic trials. Also, healthcare facilities can implement both active and reactive measures to support trial participants, such as establishing a local researcher– participant support platform.","claims":[{"public_id":"cl_20259f980c6d4955f9035e21bb987765","status":"active","text":"Lack of adequate information contributed to widespread apprehension, scepticism, and low trust towards vaccine research among ethnic minority and vulnerable groups.","confidence":0.85,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_20259f980c6d4955f9035e21bb987765"},{"public_id":"cl_d332ec90ba9e03e09388f4805b75fb4c","status":"active","text":"Most interviewees were extremely uncomfortable with attending hospitals for COVID-19 vaccine trials and any research requiring physical examinations or blood tests, citing fears of contracting COVID-19, side effects, lack of support, and language barriers.","confidence":0.9,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_d332ec90ba9e03e09388f4805b75fb4c"},{"public_id":"cl_fb5a6f736da1b8f34b38c836629f9dec","status":"active","text":"Participants expressed suspicion of hidden agendas behind vaccines and emphasized the need for transparency at all stages of vaccine trials, from development to outcomes.","confidence":0.85,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_fb5a6f736da1b8f34b38c836629f9dec"},{"public_id":"cl_84182f88afc90a1559b44b6f2a7696d4","status":"active","text":"Religious concerns were more strongly expressed among South Asian participants, while homeless people and mental health sufferers emphasized the need for third sector involvement in vaccine trials.","confidence":0.85,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_84182f88afc90a1559b44b6f2a7696d4"},{"public_id":"cl_1bc39ef74d39d14f364dbeac8409a07f","status":"active","text":"Three focus groups and 47 semi-structured interviews with 70 participants from South Asian, African and Afro-Caribbean, White Polish, White British, and other vulnerable groups (mental health, homeless, and Gypsy, Roma and Traveller communities) were conducted via virtual platforms and telephone calls in July–August 2020, using thematic analysis.","confidence":0.9,"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/claims/cl_1bc39ef74d39d14f364dbeac8409a07f"}],"concepts":[{"public_id":"co_03338e916c1c1b740d80c9e9fe87953a","status":"active","name":"semi-structured interviews","description":"A qualitative data collection method using flexible interview guides, 47 of which were conducted with participants.","types":["method"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_03338e916c1c1b740d80c9e9fe87953a"},{"public_id":"co_33abfaabd3eb7d2bb662644e8e5dfb86","status":"active","name":"South Asian communities","description":"Participants of South Asian ethnic background in the study sample, among whom religious concerns about vaccine trials were more strongly expressed.","types":["population group"],"aliases":["South Asian"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_33abfaabd3eb7d2bb662644e8e5dfb86"},{"public_id":"co_34abd5b9d8dcb5dd3d7eb1d623c6d213","status":"active","name":"Patient and Public Involvement network","description":"An existing network of patients and public contributors through which study participants were recruited.","types":["resource"],"aliases":["PPI network","PPI networks"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_34abd5b9d8dcb5dd3d7eb1d623c6d213"},{"public_id":"co_4affe79a385f69acd2e69e16e6d791f9","status":"active","name":"trust in vaccine research","description":"The degree of confidence participants place in the legitimacy and safety of vaccine research, found to be low due to insufficient information.","types":["outcome","attitude"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_4affe79a385f69acd2e69e16e6d791f9"},{"public_id":"co_4e8a1365ae9903ec210e63ab6c7001b0","status":"active","name":"vulnerable groups","description":"Populations such as people with mental health conditions, homeless people, and vulnerable migrants studied alongside ethnic minorities.","types":["population group"],"aliases":["vulnerable communities"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_4e8a1365ae9903ec210e63ab6c7001b0"},{"public_id":"co_6382b68ad6e5366aaac2ea5b898725a1","status":"active","name":"hospital attendance","description":"In-person attendance at a hospital for vaccine trial procedures such as physical examinations or blood tests.","types":["practice","concern"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_6382b68ad6e5366aaac2ea5b898725a1"},{"public_id":"co_774966294859fe0aa7b5237edc02f28b","status":"active","name":"third sector involvement","description":"Participation of voluntary and community sector organizations in supporting engagement with vaccine trials, particularly for homeless people and mental health sufferers.","types":["facilitator","resource"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_774966294859fe0aa7b5237edc02f28b"},{"public_id":"co_78067e995237afeba41f052e6e0fae71","status":"active","name":"thematic analysis","description":"A qualitative analysis method used to identify and analyze themes across interview and focus group transcripts.","types":["method"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_78067e995237afeba41f052e6e0fae71"},{"public_id":"co_a5d8388ac1dfab8a0f3d50a36de4e345","status":"active","name":"COVID-19 vaccine trials","description":"Clinical trials testing vaccines against COVID-19, whose participation and recruitment were the focus of this study.","types":["study topic"],"aliases":["vaccine trials"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_a5d8388ac1dfab8a0f3d50a36de4e345"},{"public_id":"co_dccb17cb304369266a54c20597643eab","status":"active","name":"focus groups","description":"A qualitative data collection method using group discussions, three of which were conducted in this study.","types":["method"],"aliases":[],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_dccb17cb304369266a54c20597643eab"},{"public_id":"co_e1767c043a5fbaa5c075e8ed5504030a","status":"active","name":"trial transparency","description":"Openness about vaccine development and trial outcomes, identified by participants as a key need.","types":["theme"],"aliases":["transparency"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_e1767c043a5fbaa5c075e8ed5504030a"},{"public_id":"co_fa207469ce5d313ec1c66ed8a7596a9c","status":"active","name":"ethnic minority communities","description":"Black, Asian, and other minority ethnic populations whose views on vaccine trial participation were examined.","types":["population group"],"aliases":["ethnic minority groups","minority ethnic populations"],"contributors":[{"id":17,"public_id":"322360f1c1","public_label":"Killer Whale (322360f1c1)","roles":["extraction"],"url":"https://sah.borca.ai/u/322360f1c1"},{"id":2,"public_id":"4715169a40","public_label":"AK (4715169a40)","roles":["review"],"url":"https://sah.borca.ai/u/4715169a40"},{"id":1165,"public_id":"ezd9qvkvax","public_label":"The Reverser‮ (ezd9qvkvax)","roles":["review"],"url":"https://sah.borca.ai/u/ezd9qvkvax"}],"url":"https://sah.borca.ai/concepts/co_fa207469ce5d313ec1c66ed8a7596a9c"}],"external_ids":{"DOI":"10.1093/pubmed/fdaa196","ArXiv":null,"PubMed":33124667,"PubMedCentral":"7665601","MAG":3096660133,"DBLP":null,"ACL":null},"open_access":{"is_open_access":true,"pdf_url":"https://academic.oup.com/jpubhealth/article-pdf/43/2/e258/38502703/fdaa196.pdf","landing_url":"https://www.semanticscholar.org/paper/2baf65ad0c5950ac6246e0837f8503788aea1b5f","source":"semantic_scholar","pdf_url_source":"semantic_scholar_open_access_pdf","license":"other-oa","status":"HYBRID","reason":null},"reference_availability":{"status":"available","references_indexed":true,"full_text_available":false,"full_text_source":null,"count_basis":"semantic_scholar_metadata","extraction_status":"not_applicable","reason":null},"source":{"provider":"episteme2","base_corpus":"semantic_scholar_dump","freshness_mode":"unknown","basis":["semantic_scholar_metadata","postgres_metadata"],"limits":["paper metadata is based on indexed upstream scholarly datasets","claims and concepts are available only for extracted papers","absence of claims or concepts means no extracted graph data is available in this response"],"status":"available","degraded":false,"degraded_reasons":[],"diagnostics":{"status":"available","degraded":false,"degraded_reasons":[],"metadata_status":"available","graph_status":"available","abstract_status":"available"},"source_flags":5},"paper_id":631807,"paper_uid":"fc6dc2b4-fc18-4a30-9068-dd12d9bd6fdd","canonical_identity":{"paper_id":631807,"paper_uid":"fc6dc2b4-fc18-4a30-9068-dd12d9bd6fdd","identity_status":"available","lookup_basis":"semantic_scholar_external_id","compatibility_path":"corpus_id"},"url":"https://sah.borca.ai/papers/226206577"}